Dr. Anthony Fauci, the nation’s top infectious disease expert, warned this week that the nation could see a surge of coronavirus cases and deaths in the coming months. “The models tell us if we don’t do what we need to in the fall and winter, we could have 300,000-400,000 COVID-19 […]

It’s too early to say which company — or companies — will win the coronavirus vaccine race. But we do have tools to identify the most promising players. It’s important to look at timelines, clinical trial data, and a company’s ability to fund and manufacture billions of doses of a […]

Shares of Opko Health  (OPK) – Get Report jumped on Tuesday after the drugmaker said it would start a Phase 2 clinical trial of rayaldee, a potential treatment for mild-to-moderate coronavirus.  The trial will be a randomized double-blind placebo-controlled study that is expected to enroll about 160 subjects. Many of the […]

Gilead Sciences CEO Daniel O’Day told CNBC on Monday that the company is continuing to study new ways to use its coronavirus treatment remdesivir on patients, including potentially outside of the hospital all together.  “We’re not finished with remdesivir,” O’Day said on “Squawk Box,” one day after the biopharmaceutical company announced a $21 billion […]